Vivo Capital, LLC - Q1 2023 holdings

$1.44 Billion is the total value of Vivo Capital, LLC's 48 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 8.3% .

 Value Shares↓ Weighting
SVA  Sinovac Biotech Ltd.$615,369,410
+1611954.1%
5,900,0000.0%42.70%
+871.6%
GTH  Genetron Holdings Ltdads$104,570,306
+1149150.5%
8,124,1740.0%7.26%
+592.4%
VRNA  Verona Pharma PLCads$85,338,353
+2346294.1%
4,249,9180.0%5.92%
+1313.4%
HRMY  Harmony Biosciences Holdings Inc$85,093,965
+59156.0%
2,606,2470.0%5.90%
-64.3%
TERN  Terns Pharmaceuticals Inc$78,830,625
+116207.1%
6,657,9920.0%5.47%
-29.9%
VRDN  Viridian Therapeutics Inc$42,693,586
+86994.2%
1,678,2070.0%2.96%
-47.5%
GERN  Geron Corp$41,843,750
+89570.3%
19,282,8340.0%2.90%
-46.0%
AVDL BuyAvadel Pharmaceuticals PLCadr$34,454,772
+174628.8%
3,761,438
+36.6%
2.39%
+5.3%
TARS  Tarsus Pharmaceuticals Inc$28,435,854
+85643.1%
2,262,2000.0%1.97%
-48.3%
 Astria Therapeutics Inc$22,359,947
+89221.9%
1,681,1990.0%1.55%
-46.1%
PCVX  Vaxcyte Inc$21,719,960
+78065.9%
579,5080.0%1.51%
-52.9%
COGT  Cogent Biosciences Inc$21,525,413
+93237.1%
1,994,9410.0%1.49%
-43.7%
KDNY  Chinook Therapeutics Inc$20,190,296
+88260.2%
872,1510.0%1.40%
-46.8%
SellVentyx Biosciences Inc$20,169,513
+47096.7%
602,075
-53.8%
1.40%
-71.5%
VECT  VectivBio Holding AG$19,856,383
+98111.4%
2,333,3000.0%1.38%
-40.8%
ALXO  ALX Oncology Holdings Inc$19,074,617
+40006.4%
4,220,0480.0%1.32%
-75.8%
ALLK  Allakos Inc$18,334,596
+52749.6%
4,120,1340.0%1.27%
-68.2%
ZLAB BuyZai Lab Ltd ADRadr$13,857,446
+133157.5%
416,640
+23.0%
0.96%
-19.6%
LEGN  Legend Biotech Corp Sponsoredsponsored ads$11,783,763
+96496.1%
244,3750.0%0.82%
-41.8%
CMPX SellCompass Therapeutics Inc$11,628,195
+64880.1%
3,556,023
-0.0%
0.81%
-60.8%
AMRS  Amyris, Inc$10,541,126
+88787.1%
7,750,8280.0%0.73%
-46.4%
NewArcellx Inc.$8,956,868290,713
+100.0%
0.62%
TIL  Instil Bio Inc$8,251,269
+104784.6%
12,486,7870.0%0.57%
-36.8%
BLU  Bellus Health Inc$7,323,494
+87491.1%
1,017,1520.0%0.51%
-47.2%
ACRS  Aclaris Therapeutics, Inc.$7,269,925
+51266.7%
898,6310.0%0.50%
-69.1%
 Sera Prognostics Inc$7,108,522
+303812.9%
1,856,0110.0%0.49%
+83.3%
KALV  KalVista Pharmaceuticals Inc.$6,728,223
+116164.4%
856,0080.0%0.47%
-29.9%
DYN  Dyne Therapeutics Inc$6,654,436
+99294.1%
577,6420.0%0.46%
-40.1%
MRUS SellMerus NV$6,506,240
+95791.5%
353,600
-19.4%
0.45%
-42.3%
 Aadi Bioscience Inc$6,456,277
+98650.0%
509,5720.0%0.45%
-40.5%
OLMA  Olema Pharmaceuticals Inc$5,862,617
+141543.3%
1,689,5150.0%0.41%
-14.7%
 IO Biotech Inc$5,654,147
+81418.8%
3,015,5450.0%0.39%
-50.9%
BOLT  Bolt Therapeutics Inc$5,381,094
+106816.2%
3,871,2910.0%0.37%
-35.6%
DBVT  DBV Technologies SAsponsored adr$4,577,999
+110346.3%
2,708,8750.0%0.32%
-33.3%
IMPL  Impel NeuroPharma Inc$4,038,705
+9233.3%
2,884,7890.0%0.28%
-94.4%
IOVA  Iovance Biotherapeutics Inc$4,002,398
+95513.9%
655,0570.0%0.28%
-42.3%
ARWR  Arrowhead Pharmaceuticals Inc$3,490,239
+62527.7%
137,4110.0%0.24%
-62.3%
ALGS  Aligos Therapeutics Inc$3,100,104
+91619.1%
3,547,0300.0%0.22%
-44.7%
GRCL BuyGracell Biotechnologies Incsponsored ads$2,723,008
+123057.3%
1,463,983
+52.3%
0.19%
-25.9%
BCAB  BioAtla Inc$1,707,645
+32383.3%
637,1810.0%0.12%
-80.5%
ASLN  Aslan Pharmaceuticals Ltdads$1,636,364
+159857.4%
2,840,9090.0%0.11%
-3.4%
CDXS  Codexis, Inc$1,606,916
+88729.0%
388,1440.0%0.11%
-46.2%
FULC NewFulcrum Therapeutics Inc$1,567,500550,000
+100.0%
0.11%
IMUX  Immunic Inc$941,954
+112979.7%
632,1840.0%0.06%
-32.3%
RZLT  Rezolute Inc$939,788
+92672.8%
489,4730.0%0.06%
-44.4%
 Minerva Surgical Inc$486,339
+98150.3%
2,215,6670.0%0.03%
-40.4%
FIXX  Homology Medicines, Inc.$381,170
+81696.1%
370,0680.0%0.03%
-51.9%
DTIL  Precision Biosciences Inc$105,696
+63191.0%
140,2550.0%0.01%
-63.2%
ExitCincor Pharma Inc$0-421,635
-100.0%
-0.60%
VERA ExitVera Therapeutics Inc$0-400,666
-100.0%
-0.89%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ACLARIS THERAPEUTICS INC29Q3 202333.5%
CODEXIS INC29Q3 20238.0%
ASCENDIS PHARMA A/S25Q3 202224.0%
KALVISTA PHARMACEUTICALS INC25Q3 20233.9%
Verona Pharma PLC ADR24Q3 20237.6%
AMYRIS INC23Q3 20238.8%
EIGER BIOPHARMACEUTICALS INC23Q1 20228.7%
Zai Lab Ltd ADR22Q3 20231.8%
Arrowhead Pharmaceuticals Inc21Q3 20236.9%
HOMOLOGY MEDICINES INC21Q3 20233.7%

View Vivo Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Vivo Capital, LLC Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SINOVAC BIOTECH LTDSold outAugust 27, 201800.0%

View Vivo Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-08
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-15

View Vivo Capital, LLC's complete filings history.

Compare quarters

Export Vivo Capital, LLC's holdings